What I am working with: WXT · identity confirmation by mass spectrometry. I have worked this out and I would like someone to find the error, because I suspect there…
coa
Page 28 of 32 · 749 questions tagged coa.
I am comparing a supplier certificate against an independent result on the same lot. I would like to know the limits of what can be inferred from this. What I am…
Setup, so nobody has to ask: orforglipron · two weeks · 40 °C. I am trying to build something sustainable rather than something thorough that I will abandon. I have…
The specifics, since they change the answer: GGPeps · an endotoxin test. I would like the arithmetic checked rather than the conclusion asserted. I have deliberately…
I have been through one internal appeal already and would like to do the next one properly. I can parse the result. I am less sure what it licenses me to conclude. I…
Details up front: mazdutide · lot-specific certificate. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at…
What I am working with: an endotoxin test · mazdutide. Both of these get recommended confidently by different people, which suggests neither is obviously right. My…
For reference: method section · Homopeptide. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
For reference: date of analysis · QST. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
The case in front of me: survodutide · four weeks · minus 20 °C. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in…
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. I want a method I can write down and repeat, not a rule of thumb. I would…
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. I want a method I can write down and repeat, not a rule of thumb. I would…
This is a United States plan; I appreciate the answer is jurisdiction-specific. I have read the primary source rather than the summary, which has left me with more…
The method section is present, which is unusual enough that I want to make use of it. I am trying to do this correctly the first time rather than learn it by getting…
The specifics, since they change the answer: 97.9% · list of related substances. I have the document in front of me and I can read the numbers. What I cannot do is…
Conditions: chromatogram · MKM. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like the plan to…
What I am working with: an endotoxin test · a GLP-1 receptor agonist. Both of these get recommended confidently by different people, which suggests neither is…
The method section is present, which is unusual enough that I want to make use of it. I would like help reading this properly rather than being told what conclusion…
I have both a purity figure and a content figure, which is why the discrepancy is visible. I have the document in front of me and I can read the numbers. What I…
Numbers first: KP · a Karl Fischer water content test. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay this…
I have kept every message, invoice and document, which I gather is the useful habit. I would rather be corrected now than propagate something wrong. I am specifically…
Concretely: survodutide · method section. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
Stated plainly: lot-specific certificate · WWB. I am trying to build something sustainable rather than something thorough that I will abandon. I have already decided…
The lot number on the vial matches the certificate, which at least rules out the easy problem. I would like to know the limits of what can be inferred from this. What…